
Shares of Ltd. fell 2.12 per cent to Rs 707.5 in Friday's session as of 12:58PM (IST) even as the equity benchmark Sensex traded 337.3 points lower at 56977.98.
Earlier in the day, the stock witnessed a gap up start to the session. The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 620.55 on NSE. Around 41193 shares changed hands on the counter till 12:58PM (IST).
The stock opened at Rs 725.8 and has touched an intraday high and low of Rs 725.8 and Rs 706.25 during the session so far. The scrip quoted a price-to-earnings (PE) ratio of 7.94, earnings per share (EPS) of Rs 89.0 and price to book value (PB) of 2.36, while the return on equity (ROE) stood at Rs 24.32.
Promoter/ FII Holding
The promoters held 51.83 per cent stake in the company as of December 24, while FII and MF ownerships stood at 23.41 per cent and 9.28 per cent, respectively.
Key Financials
With a market capitalisation of Rs 41425.86 crore, the company operates in the Pharma - Indian industry. For the quarter ended 30-Sep-2021, the company reported consolidated sales of Rs 6038.5 crore, up 4.41 per cent from the previous quarter?s Rs 5783.29 crore and up 7.63 per cent from the same quarter a year ago. The company reported net profit of Rs 696.99 crore for the latest quarter, down 13.55 per cent from the corresponding quarter last year.
Technical Indicators
The relative strength index (RSI) of the stock stands at 55.64. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation ratio.
Earlier in the day, the stock witnessed a gap up start to the session. The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 620.55 on NSE. Around 41193 shares changed hands on the counter till 12:58PM (IST).
The stock opened at Rs 725.8 and has touched an intraday high and low of Rs 725.8 and Rs 706.25 during the session so far. The scrip quoted a price-to-earnings (PE) ratio of 7.94, earnings per share (EPS) of Rs 89.0 and price to book value (PB) of 2.36, while the return on equity (ROE) stood at Rs 24.32.
Promoter/ FII Holding
The promoters held 51.83 per cent stake in the company as of December 24, while FII and MF ownerships stood at 23.41 per cent and 9.28 per cent, respectively.
Key Financials
With a market capitalisation of Rs 41425.86 crore, the company operates in the Pharma - Indian industry. For the quarter ended 30-Sep-2021, the company reported consolidated sales of Rs 6038.5 crore, up 4.41 per cent from the previous quarter?s Rs 5783.29 crore and up 7.63 per cent from the same quarter a year ago. The company reported net profit of Rs 696.99 crore for the latest quarter, down 13.55 per cent from the corresponding quarter last year.
Technical Indicators
The relative strength index (RSI) of the stock stands at 55.64. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation ratio.
Pick the best companies to invest
BECOME AN ETPRIME MEMBERRead More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Pick the best stocks for yourself
Powered by